Fast Search & Transfer(TM) (OSE:FAST) (FAST(TM)), a leading developer of search technologies and Invitrogen Corporation (Nasdaq:IVGN), an industry leading provider of products and services for disease research and drug discovery, today announced that Invitrogen has implemented FAST ESP(TM) to enhance the scientific search and navigation capabilities within their award winning website. After considering a number of enterprise search solutions, Invitrogen selected FAST's open architecture search platform to meet their expanding search technology needs and replaced its existing Google Appliance with FAST ESP in May 2007.With the addition of FAST technology, Invitrogen seeks to deploy new online scientific search and navigation capabilities within its product and information portfolio, better enabling scientists to efficiently find and configure relevant products in their area of research. This capability addresses a fundamental search need by assisting scientists in solving complex research problems. Having recently launched iGene, an online tool that allows scientists to search over 250,000 gene and protein products and freely access related scientific gene and pathway information, Invitrogen is expanding upon its knowledge of scientific relationships between products with the implementation of FAST.
"We want to help scientists find the answers they are looking for," said Michael Stapleton, Vice President of Global Marketing and eBusiness at Invitrogen. "FAST is a highly innovative search platform that provides relevant, intuitive results and is an important addition to our suite of web-based bioinformatics tools."
"In the life sciences industry, search plays a pivotal role in helping companies deliver the right information to customers and maintaining their competitive advantage on the web," said Michael Tupanjanin, Executive Vice President of Global Sales at FAST. "Invitrogen's search-based innovations position the company well for continued strong customer satisfaction. FAST is pleased to be able to partner with Invitrogen to provide this crucial search function."
About Invitrogen
Invitrogen Corporation (Nasdaq:IVGN) provides products and services that support academic and government research institutions and pharmaceutical and biotech companies worldwide in their efforts to improve the human condition. The company provides essential life science technologies for disease research, drug discovery, and commercial bioproduction. Invitrogen's own research and development efforts are focused on breakthrough innovation in all major areas of biological discovery including functional genomics, proteomics, bioinformatics and cell biology -- placing Invitrogen's products in nearly every major laboratory in the world. Founded in 1987, Invitrogen is headquartered in Carlsbad, California, and conducts business in more than 70 countries around the world. The company is celebrating 20 years of accelerating scientific discovery. Invitrogen globally employs approximately 4,300 scientists and other professionals and had revenues of more than $1.15 billion in 2006. For more information, visit www.invitrogen.com
About FAST
FAST creates the real-time search and business intelligence solutions that are behind the scenes at the world's best-known companies with the most demanding information challenges. FAST's flexible and scalable integrated technology platform and personalized portal connects users, regardless of medium, to the relevant information they need.
FAST is headquartered in Norway and is publicly traded under the ticker symbol 'FAST' on the Oslo Stock Exchange. The FAST Group operates globally with presence in Europe, the United States, Asia, Australia, the Americas, and the Middle East. For further information about FAST, please visit www.fastsearch.com
No comments:
Post a Comment